Bio-Synthesis provides end-to-end oligonucleotide analytical method support from scouting and optimization to client method transfer, verification and full ICH Q2(R2) validation. Development can be configured for RUO, GLP, diagnostic, release QC, stability or cGMP-oriented programs.
Scouting, optimization, transfer, verification and ICH Q2(R2) validation for DNA and RNA oligonucleotide identity, purity, impurity, residual, elemental and general attribute assays.
Assays can cover identity by LC-MS or MALDI, purity and impurities by HPLC, CE or IEX, residual solvents by GC, elemental impurities by ICP-MS and general attributes such as Karl Fischer water, pH, osmolality and optional sodium content trending.
Final validation scope should be aligned to the oligo modality, method purpose, intended use, risk level and documentation expectations.